Table 2 General distribution and outcome type of new cases of drug-resistant tuberculosis, according to characteristics of block II, Brazil, 2013 and 2014
Total (980 cases) | Success treatment | Lost to follow-up | Failure | Death | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | N | % | |
Block II | ||||||||||
Cavitation | ||||||||||
Yes | 753 | 76.8 | 474 | 62.9 | 127 | 16.9 | 62 | 8.2 | 90 | 12.0 |
No | 227 | 23.2 | 147 | 64.8 | 36 | 15.9 | 14 | 6.2 | 30 | 13.2 |
Bilateral disease | ||||||||||
Yes | 614 | 62.7 | 369 | 60.1 | 101 | 16.4 | 57 | 9.3 | 87 | 14.2 |
No | 366 | 37.3 | 252 | 68.9 | 62 | 16.9 | 19 | 5.2 | 33 | 9.0 |
Resistance type | ||||||||||
Primary | 231 | 23.6 | 166 | 71.9 | 32 | 13.9 | 15 | 6.5 | 18 | 7.8 |
Acquired | 749 | 76.4 | 455 | 60.7 | 131 | 17.5 | 61 | 8.1 | 102 | 13.6 |
Initial resistance pattern | ||||||||||
MDR/RR | 965 | 98.5 | 616 | 63.8 | 162 | 16.8 | 74 | 7.7 | 113 | 11.7 |
XDR | 15 | 1.5 | 5 | 33.3 | 1 | 6.7 | 2 | 13.3 | 7 | 46.7 |
Initial scheme type | ||||||||||
Individualized | 873 | 89.1 | 558 | 63.9 | 142 | 16.3 | 66 | 7.6 | 107 | 12.3 |
Standardized | 107 | 10.9 | 63 | 58.9 | 21 | 19.6 | 10 | 9.3 | 13 | 12.1 |
Fluoroquinolone treatment | ||||||||||
Only used Lfx or Mfx | 935 | 95.4 | 594 | 63.5 | 158 | 16.9 | 70 | 7.5 | 113 | 12.1 |
Only used Ofx | 12 | 1.2 | 6 | 50.0 | 3 | 25.0 | 2 | 16.7 | 1 | 8.3 |
Used more than one fluorquinolone or did not use | 33 | 3.4 | 21 | 63.6 | 2 | 6.1 | 4 | 12.1 | 6 | 18.2 |
Injectable drug treatment | ||||||||||
Just used Am | 242 | 24.7 | 151 | 62.4 | 41 | 16.9 | 17 | 7.0 | 33 | 13.6 |
Only used S | 607 | 61.9 | 391 | 64.4 | 103 | 17.0 | 41 | 6.8 | 72 | 11.9 |
Only used Cm | 49 | 5.0 | 30 | 61.2 | 10 | 20.4 | 5 | 10.2 | 4 | 8.2 |
Used more than one injectable or did not use | 82 | 8.4 | 49 | 59.8 | 9 | 11.0 | 13 | 15.9 | 11 | 13.4 |
Total | 980 | 100.0 | 621 | 63.4 | 163 | 16.6 | 76 | 7.8 | 120 | 12.2 |